B cell prolymphocytic leukemia patients differ from those with B cell chronic lymphocytic leukemia in –
**Core Concept**
B cell prolymphocytic leukemia (B-PLL) and B cell chronic lymphocytic leukemia (B-CLL) are both types of mature B cell neoplasms characterized by clonal proliferation of malignant B cells. However, they differ in clinical presentation, morphology, and prognosis.
**Why the Correct Answer is Right**
B-PLL is distinguished from B-CLL by the presence of a higher proportion of prolymphocytes, which are immature B cells, in the peripheral blood and bone marrow. Prolymphocytes are larger than small lymphocytes and have more prominent nucleoli. This morphological difference is due to the increased cell turnover and proliferation rate in B-PLL compared to B-CLL. The higher proliferation rate in B-PLL is associated with a more aggressive clinical course and shorter survival.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because B-PLL and B-CLL both involve mature B cells, but the proportion of prolymphocytes is higher in B-PLL.
**Option B:** Incorrect because B-PLL and B-CLL both have a similar immunophenotypic profile, including surface expression of CD19, CD20, and CD23.
**Option C:** Incorrect because B-PLL and B-CLL both respond to similar treatments, including chemotherapy and targeted therapies.
**Clinical Pearl / High-Yield Fact**
B-PLL is a rare and aggressive subtype of B cell leukemia that requires prompt recognition and treatment. The presence of prolymphocytes in the peripheral blood and bone marrow should raise suspicion for B-PLL, especially in patients with a history of B cell malignancy or lymphadenopathy.
**Correct Answer:**